Date
- 2026 (26)
- 2025 (24)
- 2024 (40)
- 2023 (48)
- 2022 (26)
- 2021 (101)
- 2020 (61)
- 2019 (126)
- 2018 (40)
- 2017 (21)
- 2016 (22)
- 2015 (14)
- 2014 (22)
- 2013 (8)
- 2012 (3)
- 2010 (2)
- 2009 (10)
- 2008 (5)
- 2007 (12)
- 2006 (10)
- 2005 (12)
- 2004 (4)
- 2003 (2)
- 2002 (6)
- 2001 (3)
- 2000 (11)
- 1999 (5)
- 1998 (3)
- 1997 (1)
- 1996 (7)
- 1995 (2)
- 1994 (6)
- 1993 (5)
- 1991 (19)
Sponsor content
707 result(s) found, displaying 451 to 460
-
TAXOTERE docetaxel 160mg/8mL concentrated injection vial Cancelled under Section 30(1)(c) of the Act
Cancellation by sponsorRequested by Sanofi-Aventis Australia Pty Ltd -
Cancellation by sponsorRequested by Sanofi-Aventis Australia Pty Ltd
-
Cancellation by sponsorRequested by Sanofi-Aventis Australia Pty Ltd
-
Cancellation by sponsorRequested by Sanofi-Aventis Australia Pty Ltd
-
Cancellation by sponsorRequested by Sanofi-Aventis Australia Pty Ltd
-
Australian Public Assessment Report (AusPAR)Australian Public Assessment Report for Live, attenuated, chimeric yellow fever dengue virus (serotypes 1, 2, 3 and 4)
-
LOVENOX enoxaparin sodium 40 mg/0.4 mL injection ampoule Cancelled under Section 30(1)(c) of the Act
Cancellation by sponsorRequested by Sanofi-Aventis Australia Pty Ltd -
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TOUJEO SOLOSTAR insulin glargine 300 units/mL solution for injection injector pen.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Sanofi-Aventis Australia Pty Ltd - Basic insulin pen, replaceable-cartridge.